Quantbot Technologies LP Takes $979,000 Position in Astera Labs, Inc. $ALAB

Quantbot Technologies LP acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 2,026 shares of the company’s stock, valued at approximately $979,000.

Several other large investors have also bought and sold shares of the business. BlackRock Inc. bought a new position in Astera Labs in the second quarter valued at about $6,609,581,000. Atreides Management LP boosted its stake in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Amundi boosted its stake in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership bought a new stake in shares of Astera Labs during the 4th quarter valued at approximately $148,980,000. Finally, Goldman Sachs Group Inc. increased its position in Astera Labs by 189.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the sale, the director owned 4,631 shares of the company’s stock, valued at approximately $2,083,950. The trade was a 66.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 419,244 shares of company stock valued at $163,135,169 over the last three months. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Price Performance

Shares of ALAB stock opened at $290.30 on Thursday. The stock has a market capitalization of $50.36 billion, a PE ratio of 143.71 and a beta of 3.84. The business’s 50 day simple moving average is $347.19 and its 200 day simple moving average is $248.42. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the business earned $0.44 EPS. The company’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Needham & Company LLC increased their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price on the stock in a research note on Monday, August 17th. Barclays upped their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Royal Bank Of Canada raised their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Finally, Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.